Patients with stage IIB or III colon cancer who had undergone curative resection were randomly assigned to receive UFT ( @ mg/m ( @ ) ) plus leucovorin ( @ mg/day ) for @ months ( control group , @ weeks of treatment followed by a @-week rest , five courses ) or for @ months ( study group , @ days of treatment followed by a @-day rest , @ courses ) .